Free DNA--new potential analyte in clinical laboratory diagnostics?

Area of Science:

• Molecular Biology
• Clinical Diagnostics
• Biochemistry

Background:

• Cell-free DNA (cfDNA) has been recognized in human circulation since the 1950s, with intensive research over the past decade.
• cfDNA analysis has evolved significantly due to advancements in molecular detection techniques.

Purpose of the Study:

• To provide an overview of current cell-free DNA research across diverse clinical fields and pathological conditions.
• To explore the potential applications of cfDNA as a diagnostic analyte in clinical laboratory settings.

Main Methods:

• Review of existing literature on cell-free DNA research.
• Discussion of advanced techniques including next-generation sequencing, digital PCR, and mass spectrometry for cfDNA detection.
• Consideration of pre-analytical and analytical aspects for standardization.

Main Results:

• Cell-free DNA is currently most utilized for non-invasive prenatal diagnosis (NIPD) of fetal sex and RhD status.
• Emerging applications include oncology for tumor detection/monitoring via tumor-derived nucleic acids and transplantation medicine for rejection markers.
• New techniques enable detection of minute cfDNA quantities amidst background nucleic acids.

Conclusions:

• Cell-free DNA holds significant potential as a versatile biomarker in various medical fields.
• Standardization of pre-analytical and analytical procedures is essential before widespread clinical implementation.
• Ethical, legal, and social implications, particularly in NIPD, require thorough discussion.